Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06745258 · ClinicalTrials.gov registry record
ICARE-LCS QUERI Partnered Evaluation Initiative: Integrating Comprehensive Tobacco Treatment to Enhance Lung Cancer Screening
A clinical trial, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- 7
- Enrollment target
NCT06745258: Clinical Trial study, sponsored by VA Office of Research and Development.
NCT06745258 is a clinical trial that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06745258 has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- 7 participants
- Enrollment target
Study Summary
Lung cancer is the leading cause of cancer-related death among Veterans with 90% of cases attributable to smoking. Lung cancer screening (LCS) combined with smoking cessation saves the most lives. ICARE-LCS seeks to decrease health inequality and improve Veteran health by reducing smoking rates among Veterans receiving LCS. ICARE-LCS will use implementation methods to inform national cancer prevention efforts and build infrastructure necessary to support broad implementation of high-impact tobacco dependence treatment (TDT) processes in LCS programs.
Primary Outcome
Participation in counseling and pharmacotherapy within 90 days of lung cancer screening referral
Interventions
- OTHER External Facilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2026-10-01 |
| Est. Completion | 2027-06-30 |
What is known before NCT06745258 opens enrollment
NCT06745258 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which External Facilitation is the first listed.
NCT06745258 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06745258 about?
NCT06745258 is a clinical study titled "ICARE-LCS QUERI Partnered Evaluation Initiative: Integrating Comprehensive Tobacco Treatment to Enhance Lung Cancer Screening". Lung cancer is the leading cause of cancer-related death among Veterans with 90% of cases attributable to smoking. Lung cancer screening (LCS) combined with smoking cessation saves the most lives. ICARE-LCS seeks to decrease health inequality and improve Veteran health by reducing smoking rates amon...
What is the current status of trial NCT06745258?
This trial is currently not yet recruiting. The enrollment target is 7 participants. The study started on 2026-10-01. Estimated completion is 2027-06-30.
What interventions are being tested in trial NCT06745258?
The interventions under investigation include: External Facilitation (OTHER).
Who is sponsoring clinical trial NCT06745258?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI